Efficacy of the echOpen Device to Detect Pyelocaliceal Dilation and Hepatic Steatosis
NCT05280145 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2024-08-26
Summary
In recent years, portable and ultra-portable ultrasound devices are increasingly used by the non radiologists, notably cardiologists or obstetrician gynecologist, at the patient's bedside to visualize and measure anatomical structures and fluid and provide the clinical examination with additional signs allowing quicker and more confident clinical decisions.
This innovative approach is slowed down by the accessibility of these miniaturized devices, the price of which remains high.
The echOpen device includes an ultra-portable ultrasound probe and a mobile application that allows the image to be displayed on a smartphone via a WIFI protocol.
The objective of the clinical investigation is to show that the echOpen device, using three frequencies 3.5 Mhz, 5.0 Mhz and 7.5 Mhz, allows identifying the semiological signs or anatomical structures of interest located at several depths of the body, with a performance similar to other devices routinely used in clinical departments.
Conditions
- Hepatic Steatosis
- Fatty Liver
- Hydronephrosis
Interventions
- DEVICE
-
EchOpen ultra-portable ultrasound device
Depending on the clinical picture, the patient is examined with EchOpen to detect the presence or absence of pyelocaliceal dilatation or hepatic steatosis
- DEVICE
-
Ultrasound device routinely used in the department
Patient who was first examined with EchOpen, is secondarily examined with an ultrasound probe used routinely in the department to detect pyelocaliceal dilatation or hepatic steatosis
- PROCEDURE
-
Ultrasound examination by an independent referent radiologist
In a case of discordance between the assessments made with echOpen and the usual ultrasound device, an independent referent radiologist will use a standard ultrasound machine to constitute the gold standard (GS) rating. If the latter is not available to carry out the third ultrasound scan within a timeframe deemed clinically acceptable, then the evaluation will be carried out in a delayed manner, using the video loops and image captures saved during the two initial ultrasound scans.
Sponsors & Collaborators
-
ECHOPEN
collaborator INDUSTRY -
EIT Health
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Jérôme BOKOBZA, MD · AP-HP, Cochin Hospital
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-21
- Primary Completion
- 2023-11-17
- Completion
- 2023-11-17
Countries
- France
Study Locations
More Related Trials
-
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
NCT03572465 ·Status: RECRUITING
-
Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
NCT01695083 ·Status: COMPLETED
-
Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
NCT07270601 ·Status: RECRUITING ·Phase: NA
-
Diagnosis of Fatty Liver With Outpatient Ultrasound
NCT03542578 ·Status: RECRUITING
-
Validation in a Non-targeted Population of Single Ultrasound Doppler Signs of Liver Fibrosis
NCT03027921 ·Status: UNKNOWN ·Phase: NA
-
Quantification of Hepatic Steatosis With Different Ultrasound Frequency
NCT05855239 ·Status: ACTIVE_NOT_RECRUITING
-
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
NCT01747772 ·Status: COMPLETED ·Phase: NA
-
Ultrasound and Attenuation Imaging
NCT06552377 ·Status: COMPLETED
-
Steatosis Assessment Pre-LDLT
NCT07015723 ·Status: ENROLLING_BY_INVITATION
-
Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
NCT01985009 ·Status: COMPLETED ·Phase: NA
-
Ultrasound Liver Fat Quantification on Pediatric Patients
NCT06095479 ·Status: COMPLETED ·Phase: NA
-
Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Examination
NCT04747457 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER
NCT04165343 ·Status: COMPLETED
-
Fatty Liver in Pregnancy
NCT00471575 ·Status: UNKNOWN
-
Referral of Patients to Hepatology With Hepatoscope
NCT06387745 ·Status: RECRUITING ·Phase: NA
-
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis
NCT07291141 ·Status: RECRUITING
-
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
NCT06176079 ·Status: RECRUITING
-
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt
NCT04861012 ·Status: UNKNOWN ·Phase: NA
-
Omics Techniques in Fatty Liver Disease
NCT05907408 ·Status: UNKNOWN
-
Ultrasound Index Fat Fraction
NCT06373796 ·Status: COMPLETED ·Phase: NA
-
Attenuation Imaging in Hepatic Steatosis
NCT05302258 ·Status: UNKNOWN
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT06487325 ·Status: COMPLETED
-
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients
NCT04785937 ·Status: RECRUITING ·Phase: NA
-
NAFLD Study: US vs Liver Biopsy
NCT04101162 ·Status: UNKNOWN ·Phase: NA